Literature DB >> 30546417

MicroRNA-182-5p contributes to the protective effects of thrombospondin 1 against lipotoxicity in INS-1 cells.

Ying Liu1,2, Jiayue Dong3, Bo Ren3.   

Abstract

The dysfunction of beta cells serves an important role in the pathogenesis of type 2 diabetes mellitus (T2DM). An improved understanding of the molecular mechanisms underlying beta cell mass and failure will be useful for identifying novel approaches toward preventing and treating this disease. Recent studies have indicated that free fatty acids (FFAs) can cause beta cell dysfunction. In the present study, palmitate (Pal) was used as a FFA and its functions on cell viability and apoptosis were detected. MTT assay and flow cytometry were used and the results revealed that incubation of INS-1 cells with Pal significantly decreased cell viability and increased cell apoptosis. However, a co-incubation with thrombospondin 1 (THBS-1) protected the cells against Pal-induced toxicity. Numerous studies have demonstrated that microRNAs (miRs) are involved in fatty acid-induced beta cell dysfunction. Various studies have reported that miR-182-5p is associated with a number of diseases, including cancer, heart disease, and leukemia. However, to the best of our knowledge miR-182-5p has never been reported to be associated with diabetes. In the present study, miR-182-5p, which is predicted to target the 3'-untranslated region (UTR) of THBS-1, was detected using reverse transcription-quantitative polymerase chain reaction in INS-1 cells in response to Pal. miR-182-5p was significantly increased in Pal-treated cells compared with the control cells. Furthermore, miR-182-5p mimics significantly decreased cell viability and increased Pal-induced apoptosis in INS-1 cells. However, cell viability was increased and Pal-induced apoptosis was decreased in cells that were treated with miR-182-5p inhibitors. The present findings also revealed that overexpression of THBS-1 counteracted the effect of miR-182-5p on cell viability and apoptosis. These results suggested that miR-182-5p is involved in the mechanism of THBS 1 on the modulation of beta cell survival.

Entities:  

Keywords:  apoptosis; beta cells; diabetes; microRNAs; palmitate

Year:  2018        PMID: 30546417      PMCID: PMC6256972          DOI: 10.3892/etm.2018.6883

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  31 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Dietary-fat-induced obesity in mice results in beta cell hyperplasia but not increased insulin release: evidence for specificity of impaired beta cell adaptation.

Authors:  R L Hull; K Kodama; K M Utzschneider; D B Carr; R L Prigeon; S E Kahn
Journal:  Diabetologia       Date:  2005-06-04       Impact factor: 10.122

3.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

Review 4.  Protein restriction and cancer.

Authors:  Jie Yin; Wenkai Ren; Xingguo Huang; Tiejun Li; Yulong Yin
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-03-26       Impact factor: 10.680

5.  miR-375 enhances palmitate-induced lipoapoptosis in insulin-secreting NIT-1 cells by repressing myotrophin (V1) protein expression.

Authors:  Yan Li; Xuejuan Xu; Ying Liang; Shanying Liu; Huisheng Xiao; Feng Li; Hua Cheng; Zuzhi Fu
Journal:  Int J Clin Exp Pathol       Date:  2010-01-25

6.  MicroRNA-182-5p Ameliorates Liver Ischemia-Reperfusion Injury by Suppressing Toll-Like Receptor 4.

Authors:  W Jiang; G Liu; W Tang
Journal:  Transplant Proc       Date:  2016-10       Impact factor: 1.066

Review 7.  Glucolipotoxicity of the pancreatic beta cell.

Authors:  Vincent Poitout; Julie Amyot; Meriem Semache; Bader Zarrouki; Derek Hagman; Ghislaine Fontés
Journal:  Biochim Biophys Acta       Date:  2009-08-26

8.  A Presenilin/Notch1 pathway regulated by miR-375, miR-30a, and miR-34a mediates glucotoxicity induced-pancreatic beta cell apoptosis.

Authors:  Yating Li; Tao Zhang; Yuncai Zhou; Yi Sun; Yue Cao; Xiaoai Chang; Yunxia Zhu; Xiao Han
Journal:  Sci Rep       Date:  2016-11-02       Impact factor: 4.379

9.  Downregulation of Bcl-2 expression by miR-34a mediates palmitate-induced Min6 cells apoptosis.

Authors:  Xiaojie Lin; Hongyu Guan; Zhimin Huang; Juan Liu; Hai Li; Guohong Wei; Xiaopei Cao; Yanbing Li
Journal:  J Diabetes Res       Date:  2014-04-14       Impact factor: 4.011

10.  Analysis of the Relationship between the Referral and Evolution of Patients with Type 2 Diabetes Mellitus.

Authors:  Camilo Alvarez; Cecilia Saint-Pierre; Valeria Herskovic; Marcos Sepúlveda
Journal:  Int J Environ Res Public Health       Date:  2018-07-20       Impact factor: 3.390

View more
  5 in total

1.  miR-182-5p combined with brain-derived neurotrophic factor assists the diagnosis of chronic heart failure and predicts a poor prognosis.

Authors:  Fang Fang; Xiaonan Zhang; Bin Li; Shouyi Gan
Journal:  J Cardiothorac Surg       Date:  2022-04-30       Impact factor: 1.522

Review 2.  Thrombospondin 1 in Metabolic Diseases.

Authors:  Linda S Gutierrez; Jovita Gutierrez
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-29       Impact factor: 5.555

Review 3.  Molecular Mechanisms of Apoptosis Induction and Its Regulation by Fatty Acids in Pancreatic β-Cells.

Authors:  Jan Šrámek; Vlasta Němcová-Fürstová; Jan Kovář
Journal:  Int J Mol Sci       Date:  2021-04-20       Impact factor: 5.923

Review 4.  Targeting microRNAs as a Therapeutic Strategy to Reduce Oxidative Stress in Diabetes.

Authors:  Giuseppina Emanuela Grieco; Noemi Brusco; Giada Licata; Laura Nigi; Caterina Formichi; Francesco Dotta; Guido Sebastiani
Journal:  Int J Mol Sci       Date:  2019-12-17       Impact factor: 5.923

Review 5.  Non-Coding RNA as Biomarkers for Type 2 Diabetes Development and Clinical Management.

Authors:  Tiange Chi; Jiaran Lin; Mina Wang; Yihan Zhao; Zehuan Liao; Peng Wei
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-17       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.